Header cover image
  • Investing Ideas
  • South Korean Pharmaceuticals & Biotech Large Cap High Growth Potential

South Korean Pharmaceuticals & Biotech Large Cap High Growth Potential

Results

1

0 new

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

1 companies

ALTEOGEN

Market Cap: ₩16.1t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

A196170

₩300,500.00

7D

8.7%

1Y

-35.0%